Scientists have developed two new AI tools, InstaNovo and InstaNovo+, to decipher proteins often missed by existing detection methods. These tools have the potential to unlock the genetic identity of previously unstudied proteins, enabling better cancer treatments, improved disease understanding, and discovery of unexplained animal abilities. The AI models have shown promise in sequencing human immune proteins, which are notoriously difficult to analyze.
Forecast for 6 months: Within the next 6 months, we can expect to see increased adoption of AI-powered protein sequencing tools in research institutions and pharmaceutical companies, leading to breakthroughs in cancer treatment and disease understanding.
Forecast for 1 year: By the end of the year, we can anticipate the development of more advanced AI models that can accurately identify and analyze proteins in complex biological samples, paving the way for new treatments and therapies.
Forecast for 5 years: In the next 5 years, AI-powered protein sequencing is likely to become a standard tool in the field of biology and medicine, leading to significant advancements in our understanding of diseases and the development of new treatments.
Forecast for 10 years: By the end of the decade, AI-powered protein sequencing is expected to have transformed the field of biology and medicine, enabling the development of personalized treatments, regenerative medicine, and potentially even the reversal of certain diseases.
